D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells

Journal of Dermatological Science

Volumn 71, Issue 1, 2013, Pages 37-44

  Mori, Tomoko ^a   Kabashima, Kenji ^b   Fukamachi, Shoko ^a   Kuroda, Etsushi ^a   Sakabe, Jun ichi ^a   Kobayashi, Miwa ^a   Nakajima, Saeko ^b   Nakano, Kazuhisa ^a   Tanaka, Yoshiya ^a   Matsushita, Sho ^c   Nakamura, Motonobu ^a   Tokura, Yoshiki ^d  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

D1 like receptor; Dopamine; Mast cells; Th2 cell

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL DIFFERENTIATION; CONTACT ALLERGY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; BENZAZEPINES; CELL DEGRANULATION; CELL DIFFERENTIATION; CELLS, CULTURED; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-4; MAST CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; TH2 CELLS; TIME FACTORS;

EID: 84879021501     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.03.008     Document Type: Article

References (27)

1. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
2. Nakae S., Ho L.H., Yu M., Monteforte R., Iikura M., Suto H., et al. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and Th2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 2007, 120:48-55.
3. Kulka M., Sheen C.H., Tancowny B.P., Grammer L.C., Schleimer R.P. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2007, 123:398-410.
4. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptor: from structure to function. Physiol Rev 1998, 78:189-225.
5. Sibley D.R., Monsma F.J., Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 1993, 35:391-415.
6. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000, 97:8104-8109.
7. Seeman P., Niznik H.B. Dopamine receptors and transporters in Parkinson's disease and shizophrenia. FASEB J 1990, 4:2737-2744.
8. Ilani T., Ben-Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., et al. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci USA 2001, 98:625-628.
9. +-T cells. J Neuroimmunol 2006, 173:180-187.
10. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee H.J., Kim D.J., et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatr 2004, 287:1129-1134.
11. Barak Y., Achiron A., Mandel M., Mirecki I., Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005, 104:2817-2821.
12. Avgustin B., Wraber B., Travcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of shizophrenia. Croat Med J 2005, 46:268-274.
13. Nakano K., Higashi T., Hashimoto K., Takagi R., Tanaka Y. Antagonizing dopamine D1-like receptor inhibit Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 2008, 373:286-291.
14. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 2005, 115:285-295.
15. Nakano K., Higashi T., Takagi R., Hashimoto K., Tanaka Y., et al. Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 2009, 21:645-654.
16. Matsushita H., Yamada N., Matsue H., Shimada S. TLR3-TLR7-, and TLR9-mediated production of proinflammtory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004, 173:531-541.
17. Nagasaka A., Matsue H., Matsushita H., Aoki R., Nakamura Y., Kambe N., et al. Osteopontin in produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008, 38:489-499.
18. Razin E., Mencia-Huerta J.M., Stevens R.L., Lewis R.A., Liu F.T., Corey E., et al. IgE-mediatied release of leukotriene C4, chondroitin sulfate E proteoglycan, ?-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med 1983, 157:189-201.
19. Noguchi J., Kuroda E., Yamashita U. Strain difference of murine bone marrow-derived mast cell function. J Leukoc Biol 2005, 78:605-611.
20. Kitagaki H., Ono N., Hayakawa T., Kitazawa T., Watanabe K., Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1998, 159:2484-2491.
21. Jin H., He R., Oyoshi M., Geha R.S. Animal models of atopic dermatitis. J Invest Dermatol 2009, 129:31-40.
22. Akiba H., Kehren J., Ducluzeau M.T., Krasteva M., Horand F., Kaiserlian D., et al. Skin inflammation during contact hypersensitivity is mediated by early rectuitment of CD8+ Tcytotoxic 1 cells inducing keratinocyte apotosis. J Immunol 2002, 158:3079-3087.
23. Kitagaki H., Fujisawa S., Watanabe K., Hayakawa K., Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 1995, 105:749-755.
24. Ying S., Kikuchi Y., Meng Q., Kay A.B., Kaplan A.P. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: compatison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002, 109:694-700.
25. Barbeau A. Dopamine and disease. Can Med Assoc J 1970, 103:824-832.
26. Giroux J.M., Dubuc R., Barbeau A. Levodopa and Ro 4-4602 in psoriasis. Lancet 1972, 2:333-334.
27. Freeman J.G., Ryan J.J., Shelburne C.P., Bailey D.P., Bouton L.A., Narasimhachari N., et al. Catecholamines in murine bone marrow derived mast cells. J Neuroimmunol 2001, 119:231-238.